Interchangeability of hepatitis A vaccines for children

Interchangeability of hepatitis A vaccines for children - Interchangeability of hepatitis A vaccines for children

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019797

Enrollment

Registered

2015-11-16

Start date

2015-11-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis A

Interventions

Single dose of HAVRIX720(0.5ml, IM)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy children

Exclusion criteria

Exclusion criteria: acute febrile illness immunodeficiency allergy against vaccine contents history of hepatitis A

Design outcomes

Primary

Measure	Time frame
Immunogenicity: Anti-HAV antibody Anti-HAV antibody will be measured on days 0 and 28 after vaccination of HAVRIX720.	—

Secondary

Measure	Time frame
Safety Adverse events will be documented by the sublects.	—

Countries

Japan

Contacts

Public ContactShinji Fukushima

Tokyo Medical University Hospital Travellers' Medical Center

fuku789@tokyo-med.ac.jp03-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026